MEI Pharma, Inc.MEIP

Market cap

$18.72M

P/E ratio

	Jun 30, 2012	Jun 30, 2013	Jun 30, 2014	Jun 30, 2015	Jun 30, 2016	Jun 30, 2017	Jun 30, 2018	Jun 30, 2019	Jun 30, 2020	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023
Revenues	-	-	-	-	-	23	2	5	29	26	41	49
Cost of revenue	-	-	-	-	-	-	-	4	3	1	-	-
Research and development	44	50	19	24	13	7	17	32	34	69	86	52
Research and development	44	50	19	24	13	7	17	32	34	69	86	52
General and administrative	23	28	8	9	8	9	10	15	17	24	31	33
General and administrative	23	28	8	9	8	9	10	15	17	24	31	33
Total operating expenses	-	-	-	-	-	21	30	51	53	95	116	86
Total operating expenses	-	-	-	-	-	21	30	51	53	95	116	86
Loss from operations	-8	-11	-27	-33	-21	2	-29	-46	-25	-70	-75	-37
Change in fair value of warrant liability	-	-	-	-	-	-	-10	28	-23	18	21	2
Interest and dividend income	3	3	0	0	0	0	1	2	1	1	0	3
Other expense, net	-	-	-	-	-	-	-	-	-	0	-0	-0
Income tax expense	0	0	0	0	0	0	0	0	0	0	-	-
Total other income, net	-	-	-	-	-	-	-	-	-	-	21	5
Total other income, net	-	-	-	-	-	-	-	-	-	-	21	5
Net loss	-8	-11	-27	-33	-21	3	-40	-17	-46	-51	-54	-32
Net loss	-8	-11	-27	-33	-21	3	-40	-17	-46	-51	-54	-32
Basic	-	-	-	-	-	-	-	-17	-46	-51	-54	-32
Diluted	-	-	-	-	-	-	-	-55	-46	-78	-62	-32
Basic	-	-	-	-	-	0.07	-0.97	-0.24	-0.51	-0.45	-0.44	-4.78
Diluted	-	-	-	-	-	0.07	-0.97	-0.75	-0.51	-0.68	-0.5	-4.78